Concepedia

Mario Mancino

MM

25

Publications

1.2K

Citations

20

H-Index

2004

Active since

Affiliations

Universitat de Barcelona(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

National Cancer Institute

National Institutes of Health

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Mario Mancino is an author at Universitat de Barcelona specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2004–2025

25

Publications

25

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

Nicola Normanno, Antonella De Luca, Monica R. Maiello et al. · Journal of Cellular Physiology · 2006 · 142 citations

Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation

Patricia Fernández‐Nogueira, Mario Mancino, Gemma Fuster et al. · Clinical Cancer Research · 2019 · 104 citations

Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer

Susana García‐Recio, Gemma Fuster, Patricia Fernández‐Nogueira et al. · Cancer Research · 2013 · 98 citations · Full text

Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer

Caterina Bianco, Luigi Strizzi, Mario Mancino et al. · Clinical Cancer Research · 2006 · 82 citations

Cripto-1 Is Required for Hypoxia to Induce Cardiac Differentiation of Mouse Embryonic Stem Cells

Caterina Bianco, Catherine J. Cotten, Enza Lonardo et al. · American Journal Of Pathology · 2009 · 76 citations · Full text

, , +7

Rows per page

1–5 of 25